The Food and Drug Administration's Financial Disclosure System for Special Government Employees: Progress and Problems : Report to the Congress |
From inside the book
Results 1-5 of 17
Page i
... approval . It also needs to develop sup- porting procedures . ( See p . 18. ) --In January 1976 , the agency issued , in draft , policy to be used on a pilot basis . Before then , conflict - of - interest issues were re- solved case by ...
... approval . It also needs to develop sup- porting procedures . ( See p . 18. ) --In January 1976 , the agency issued , in draft , policy to be used on a pilot basis . Before then , conflict - of - interest issues were re- solved case by ...
Page iii
... approval , ( 3 ) developing specific procedures to make sure policy is implemented , and ( 4 ) improving the form used to collect fi- nancial disclosure information . --Issuing guidelines clearly defining the responsibilities and ...
... approval , ( 3 ) developing specific procedures to make sure policy is implemented , and ( 4 ) improving the form used to collect fi- nancial disclosure information . --Issuing guidelines clearly defining the responsibilities and ...
Page 8
... approve standards of conduct established by each agency . In November 1965 , CSC issued instructions re- quiring each agency to prepare standards of employee conduct and to establish a system for reviewing employee financial disclosure ...
... approve standards of conduct established by each agency . In November 1965 , CSC issued instructions re- quiring each agency to prepare standards of employee conduct and to establish a system for reviewing employee financial disclosure ...
Page 12
... approve employment and determine degree of participation . ( Public disclosure of these cases is currently being used in lieu of a review board . ) c / Restricted from participating in regulatory matters or pro- viding advice regarding ...
... approve employment and determine degree of participation . ( Public disclosure of these cases is currently being used in lieu of a review board . ) c / Restricted from participating in regulatory matters or pro- viding advice regarding ...
Page 15
... approval . The new policy guidance : --Limits investments , employment , grants , and contracts in a single firm to $ 5,000 before requiring public disclosure and clarified that in all cases these limits apply only to firms involved ...
... approval . The new policy guidance : --Limits investments , employment , grants , and contracts in a single firm to $ 5,000 before requiring public disclosure and clarified that in all cases these limits apply only to firms involved ...
Other editions - View all
Common terms and phrases
advisory committee members APPENDIX II GUIDE application appointment approval cial Commissioner conflict of interest conflict-of-interest determination criteria department or agency disqualified from matters Disqualified from participation District of Columbia Drug Administration Employment and Financial executive secretaries FDA activities FDA believes FDA officials FDA policy FDA-regulated industry FDA's Federal Register financial disclosure statements Financial Disclosure System firm in past firms defined firms involved Food and Drug grant or contract grants and contracts GUIDE FDA individual Interest Statutes investigation investments involved with products involving a specific involving the firm issued ment needed officer or employee official responsibility participated personally participation involving particular matter involving past 12 months pending personally and substantially policy guidance Policy Management Staff PRDC memorandum products regulated reappointment regulated firms remuneration rendering of advice review official Section 5c SGE's participation SGE`s single firm special Government employee staff manual guide Theodore Cooper tion U.S. Geological Survey
Popular passages
Page 36 - Columbia, in relation to any proceeding, application, request for a ruling or other determination, contract, claim, controversy, charge accusation, arrest, or other particular matter in which the United States is a party or has a direct and substantial interest, before any department, agency, court-martial, officer, or any civil, military, or naval commission...
Page 36 - Government employee or as a special Government employee through decision, approval, disapproval, recommendation, the rendering of advice, investigation or otherwise, or (2) which is pending in the department or agency of the Government in which he is serving: Provided, That clause (2) shall not apply in the case of a special Government employee...
Page 36 - (c) A special Government employee shall be subject to subsection (a) only in relation to a particular matter involving a specific party or parties (1) in which he has at any time participated personally and substantially as a Government employee or as a special Government employee through decision, approval, disapproval, recommendation, the rendering of advice, investigation or otherwise, or (2...
Page 6 - ... particular matter in which, to his knowledge, he, his spouse, minor child, partner, organization in which he is serving as officer, director, trustee, partner or employee, or any person or organization with whom he is negotiating or has any arrangement concerning prospective employment, has a financial interest...
Page 7 - Government employees" as defined In Section 202 of Title 18 of the United States Code, who are employed in the Executive Branch. SEC. 302. A consultant, adviser or other special Government employee must refrain from any use of his public office which Is motivated by, or gives the appearance of being motivated by, the desire for private gain for himself or other persons, including particularly those with whom he has family, business, or financial ties.
Page 36 - Elect; or (2) At a time when he Is an officer or employee of the United States In the executive, legislative, or Judicial branch of the Government, or In any agency of the United States...
Page iv - ... Department of Health, Education, and Welfare. Commissioner Ley, we are very happy to have you come and testify this morning. Dr. LEY. Thank you, Mr. Chairman. Senator Moss. You have some gentlemen with you. Will you please identify them. Dr. LEY. On my left, Mr. Chairman, is Mr. William Goodrich, from the Office of the General Counsel, Department of Health, Education, and Welfare. On my right, immediate right, is Dr. William Ligon, from the FDA Bureau of Medicine's Hazardous Substances Laboratory.
Page 36 - (f) Whoever, otherwise than as provided by law for the proper discharge of official duty, directly or indirectly gives, offers, or promises anything of value to any public official, former public official, or person selected to be a public official, for or because of any official act...
Page 36 - Whoever, otherwise than as provided by law for the proper discharge of official duties, directly or indirectly receives or agrees to receive, or asks, demands, solicits, or seeks, any compensation for any services rendered or to be rendered either by himself or another— (1) at a time when he is a Member of Congress, Member of Congress Elect, Resident Commissioner, or Resident Commissioner Elect; or (2) at a time when he is an officer or employee of the United States in the executive, legislative,...